We are live on ! Find out more
TWST icon

Twist Bioscience
TWST

93 hedge funds and large institutions have $414M invested in Twist Bioscience in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

74% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 19

11.46% more ownership

Funds ownership: 48.14% → 59.6% (+11%)

11% more funds holding

Funds holding: 84 → 93 (+9)

11% more capital invested

Capital invested by funds: $374M → $414M (+$39.7M)

Holders
93
Holders Change
+9
Holders Change %
+10.71%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
22
Increased
33
Reduced
19
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$16.5M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$11.4M
3
BlackRock
BlackRock
New York
+$7.27M
4
Millennium Management
Millennium Management
New York
+$6.93M
5
JP Morgan Chase
JP Morgan Chase
New York
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
-$5.33M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$4.9M
3
IECM
Intrinsic Edge Capital Management
Illinois
-$4.22M
4
CM
Castleark Management
Illinois
-$3.4M
5
Barclays
Barclays
United Kingdom
-$1.52M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
1
JP Morgan Chase
New York
$54.3M +$4.42M +189,070 +8%
BlackRock
2
BlackRock
New York
$40.3M +$7.27M +310,545 +19%
TCM
3
Tao Capital Management
California
$35M +$39M +1,665,838 New
Millennium Management
4
Millennium Management
New York
$24M +$6.93M +295,995 +35%
Vanguard Group
5
Vanguard Group
Pennsylvania
$23.1M +$193K +8,245 +0.8%
Wells Fargo
6
Wells Fargo
California
$18.9M +$2.48M +105,904 +13%
State Street
7
State Street
Massachusetts
$18.7M +$384K +16,400 +2%
Capital World Investors
8
Capital World Investors
California
$14.8M +$16.5M +704,000 New
CAM
9
Cormorant Asset Management
Massachusetts
$14.4M – – –
Lord, Abbett & Co
10
Lord, Abbett & Co
New Jersey
$11.7M +$1.77M +75,706 +16%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$10.6M -$641K -27,400 -5%
Alyeska Investment Group
12
Alyeska Investment Group
Illinois
$10.2M +$11.4M +486,050 New
Massachusetts Financial Services
13
Massachusetts Financial Services
Massachusetts
$10.2M +$2.56M +109,566 +29%
ITP
14
Iron Triangle Partners
Connecticut
$10.1M +$11.3M +483,144 New
AIM
15
ARK Investment Management
Florida
$8.37M +$3.58M +152,986 +62%
DCM
16
Driehaus Capital Management
Illinois
$7.63M +$130K +5,564 +2%
EA
17
Emerald Advisers
Pennsylvania
$7M -$5.33M -227,570 -41%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$6.68M +$351K +15,004 +5%
EMFAT
19
Emerald Mutual Fund Advisers Trust
Pennsylvania
$6.61M -$4.9M -209,336 -40%
CC
20
Casdin Capital
New York
$6.3M – – –
Northern Trust
21
Northern Trust
Illinois
$5.99M +$34K +1,451 +0.5%
Victory Capital Management
22
Victory Capital Management
Texas
$5.95M -$178K -7,597 -3%
Federated Hermes
23
Federated Hermes
Pennsylvania
$4.92M – – –
GGHC
24
Gilder Gagnon Howe & Co
New York
$4.7M -$1.24M -52,819 -19%
PA
25
Perceptive Advisors
New York
$4.53M +$1.64M +70,000 +48%
1
2 3 4

TWST Hedge Fund Activity: Q4 2019 in Review

93 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2019, worth a combined $414M — up 11% from $374M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new TWST positions and 7 closed out — a net gain of 15 holders — while 33 added to existing stakes and 19 trimmed.

The largest buyer was Capital World Investors, opening a new position worth an estimated $16.5M. The largest seller was Emerald Advisers, cutting an estimated $5.33M.

  • 93 institutional investors held Twist Bioscience (TWST) as of Q4 2019, up from 84 in Q3 2019.
  • Funds reported $414M of Twist Bioscience stock for Q4 2019, up 11% quarter-over-quarter.
  • 22 funds opened new Twist Bioscience positions in Q4 2019 and 7 closed out, a net change of +15 holders.
  • The largest Twist Bioscience buyer in Q4 2019 was Capital World Investors, an estimated $16.5M added.
  • The largest Twist Bioscience seller in Q4 2019 was Emerald Advisers, an estimated $5.33M sold.

Based on aggregated 13F filings for Q4 2019.